All In Biotech

Free tool

FAERS Monitor: Adzenys Xr-Odt

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204326 or its brand name (Adzenys Xr-Odt, Amphetamine). Reports on generic versions are filed under their own applications.

Reports

6,299

Serious

5,284

84% of reports

Hospitalization

1,474

Death reported

3,007

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • toxicity to various agents1,620
  • drug abuse1,301
  • completed suicide666
  • overdose409
  • death354
  • cardiac arrest280
  • cardio-respiratory arrest266
  • drug ineffective237
  • respiratory arrest216
  • fatigue203
  • drug dependence188
  • drug interaction185
  • nausea166
  • substance abuse161
  • somnolence159

Reports by year received

View as table
YearReports
200417
200512
200613
200715
200816
20091
20107
201142
201236
2013227
2014264
2015393
2016258
2017327
2018439
2019498
2020507
2021417
2022463
2023512
2024673
2025751
2026411

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,860 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
substance abuseSignal16167.457.710,256
drug abuseSignal1,30153.050.565,546
toxicity to various agentsSignal1,62032.431.049,152
completed suicideSignal66626.925.016,511
respiratory arrestSignal21626.423.15,214
cardio-respiratory arrestSignal26621.419.05,122
cardiac arrestSignal28011.410.12,636
overdoseSignal4096.35.81,850
drug dependenceSignal1883.93.4406
drug interactionSignal1853.93.4398
somnolenceSignal1592.62.3161
death3541.41.237
fatigue2030.90.84
nausea1660.70.622
drug ineffective2370.60.567

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.